{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:02:12Z","timestamp":1762002132120,"version":"build-2065373602"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T00:00:00Z","timestamp":1662595200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016650","name":"Rare Diseases Clinical Research Network","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016650","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016853","name":"Lysosomal Disease Network","doi-asserted-by":"publisher","award":["U54NS065768"],"award-info":[{"award-number":["U54NS065768"]}],"id":[{"id":"10.13039\/100016853","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism Reports"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.ymgmr.2022.100917","type":"journal-article","created":{"date-parts":[[2022,9,18]],"date-time":"2022-09-18T08:11:56Z","timestamp":1663488716000},"page":"100917","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Identification of a novel fusion Iduronidase with improved activity in the cardiovascular system"],"prefix":"10.1016","volume":"33","author":[{"given":"Sarah","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Przybilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chester B.","family":"Whitley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Ou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud","family":"Al-Kofahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeanine R.","family":"Jarnes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgmr.2022.100917_bb0005","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s10545-013-9608-0","article-title":"Blood-brain barrier structure and function and the challenges for CNS drug delivery","volume":"36","author":"Abbott","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2022.100917_bb0010","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ymgme.2017.04.011","article-title":"Infantile gangliosidoses: mapping a timeline of clinical changes","volume":"121","author":"Jarnes Utz","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2022.100917_bb0015","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13023-018-0849-8","article-title":"Neurocognitive and somatic stabilization in pediatric patients with severe Mucopolysaccharidosis type I after 52 weeks of intravenous brain-penetrating insulin receptor antibody-iduronidase fusion protein (valanafusp alpha): an open label phase 1-2 trial","volume":"13","author":"Giugliani","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgmr.2022.100917_bb0020","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ymthe.2020.09.039","article-title":"A phase 2\/3 trial of Pabinafusp alfa, IDS fused with anti-human transferrin receptor antibody, targeting neurodegeneration in MPS-II","volume":"29","author":"Okuyama","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgmr.2022.100917_bb0025","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/s10545-011-9359-8","article-title":"Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and management","volume":"34","author":"Braunlin","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2022.100917_bb0030","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2143\/AC.60.1.2005049","article-title":"Cardiovascular changes in mucopolysaccharidoses in Taiwan","volume":"60","author":"Chen","year":"2005","journal-title":"Acta Cardiol."},{"key":"10.1016\/j.ymgmr.2022.100917_bb0035","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/s004310050872","article-title":"Cardiovascular changes in children with mucopolysaccharide storage diseases and related disorders--clinical and echocardiographic findings in 64 patients","volume":"157","author":"Dangel","year":"1998","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgmr.2022.100917_bb0040","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1017\/S1047951109003576","article-title":"The natural course and the impact of therapies of cardiac involvement in the mucopolysaccharidoses","volume":"19","author":"Fesslov\u00e1","year":"2009","journal-title":"Cardiol. Young"},{"key":"10.1016\/j.ymgmr.2022.100917_bb0045","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1017\/S104795110999062X","article-title":"Echocardiographic study of paediatric patients with mucopolysaccharidosis","volume":"20","author":"Leal","year":"2010","journal-title":"Cardiol. Young"},{"key":"10.1016\/j.ymgmr.2022.100917_bb0050","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/BF01991908","article-title":"Mitral and aortic regurgitation in 84 patients with mucopolysaccharidoses","volume":"154","author":"Wippermann","year":"1995","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgmr.2022.100917_bb0055","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/j.jpeds.2009.07.005","article-title":"Guidelines for the management of mucopolysaccharidosis type I","volume":"155","author":"Martins","year":"2009","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgmr.2022.100917_bb0060","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ymgme.2007.01.011","article-title":"The MPS I registry: design, methodology, and early findings of a global disease registry for monitoring patients with Mucopolysaccharidosis type I","volume":"91","author":"Pastores","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2022.100917_bb0065","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0002-9149(03)00909-3","article-title":"Usefulness of bone marrow transplantation in the Hurler syndrome","volume":"92","author":"Braunlin","year":"2003","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ymgmr.2022.100917_bb0070","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/adc.73.3.259","article-title":"Cardiac involvement in mucopolysaccharidoses: effects of allogeneic bone marrow transplantation","volume":"73","author":"Gatzoulis","year":"1995","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.ymgmr.2022.100917_bb0075","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jpeds.2008.11.041","article-title":"Bone marrow transplantation in children with Hunter syndrome: outcome after 7 to 17 years","volume":"154","author":"Guffon","year":"2009","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgmr.2022.100917_bb0080","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1056\/NEJM198412203112504","article-title":"Bone-marrow transplantation in the Maroteaux-Lamy syndrome (mucopolysaccharidosis type VI). Biochemical and clinical status 24 months after transplantation","volume":"311","author":"Krivit","year":"1984","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgmr.2022.100917_bb0085","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BF00798216","article-title":"Hypertrophic cardiomyopathy in mucopolysaccharidoses: regression after bone marrow transplantation","volume":"13","author":"Vi\u00f1allonga","year":"1992","journal-title":"Pediatr. Cardiol."},{"key":"10.1016\/j.ymgmr.2022.100917_bb0090","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0002-9149(01)01999-3","article-title":"Coronary artery patency following long-term successful engraftment 14 years after bone marrow transplantation in the Hurler syndrome","volume":"88","author":"Braunlin","year":"2001","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ymgmr.2022.100917_bb0095","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/sj.bmt.1701141","article-title":"Treatment of MPS VII (Sly disease) by allogeneic BMT in a female with homozygous A619V mutation","volume":"21","author":"Yamada","year":"1998","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.ymgmr.2022.100917_bb0100","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.amjcard.2006.02.047","article-title":"Cardiac findings after enzyme replacement therapy for mucopolysaccharidosis type I","volume":"98","author":"Braunlin","year":"2006","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ymgmr.2022.100917_bb0105","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1007\/s10545-007-0613-z","article-title":"Successful treatment of severe heart failure in an infant with hurler syndrome","volume":"30","author":"Hirth","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2022.100917_bb0110","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ymgme.2009.08.006","article-title":"Japan Elaprase treatment (JET) study: idursulfase enzyme replacement therapy in adult patients with attenuated hunter syndrome (Mucopolysaccharidosis II, MPS II)","volume":"99","author":"Okuyama","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2022.100917_bb0115","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1542\/peds.2006-2156","article-title":"Enzyme replacement therapy in patients who have mucopolysaccharidosis I and are younger than 5 years: results of a multinational study of recombinant human alpha-L-iduronidase (laronidase)","volume":"120","author":"Wraith","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgmr.2022.100917_bb0120","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2012.00009","article-title":"The endocannabinoid system: an overview","volume":"6","author":"Battista","year":"2012","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.ymgmr.2022.100917_bb0125","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.molbrainres.2004.08.025","article-title":"Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors","volume":"132","author":"Golech","year":"2004","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.ymgmr.2022.100917_bb0130","doi-asserted-by":"crossref","first-page":"6406","DOI":"10.4049\/jimmunol.181.9.6406","article-title":"Cannabinoids inhibit HIV-1 Gp120-mediated insults in brain microvascular endothelial cells","volume":"181","author":"Lu","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.ymgmr.2022.100917_bb0135","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1160\/TH05-06-0413","article-title":"Regulation by cannabinoid receptors of anandamide transport across the blood-brain barrier and through other endothelial cells","volume":"95","author":"Maccarrone","year":"2006","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ymgmr.2022.100917_bb0140","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nn.3053","article-title":"Mitochondrial CB1 receptors regulate neuronal energy metabolism","volume":"15","author":"B\u00e9nard","year":"2012","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ymgmr.2022.100917_bb0145","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1074\/mcp.M113.035600","article-title":"Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics","volume":"13","author":"Fagerberg","year":"2014","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.ymgmr.2022.100917_bb0150","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/ajmg.1320460222","article-title":"Long-term outcome of hurler syndrome following bone marrow transplantation","volume":"46","author":"Whitley","year":"1993","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.ymgmr.2022.100917_bb0155","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(81)91046-1","article-title":"Reversal of clinical features of Hurler's disease and biochemical improvement after treatment by bone-marrow transplantation","volume":"2","author":"Hobbs","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.ymgmr.2022.100917_bb0160","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/sj.gt.3300947","article-title":"Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA","volume":"6","author":"Liu","year":"1999","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymgmr.2022.100917_bb0165","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1006\/mthe.2000.0075","article-title":"Inclusion of the hepatic locus control region, an intron, and untranslated region increases and stabilizes hepatic factor IX gene expression in vivo but not in vitro","volume":"1","author":"Miao","year":"2000","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgmr.2022.100917_bb0170","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ymgmr.2015.11.004","article-title":"Elements of lentiviral vector design toward gene therapy for treating mucopolysaccharidosis I","volume":"8","author":"Ou","year":"2016","journal-title":"Mol. Genet. Metabol. Reports"},{"key":"10.1016\/j.ymgmr.2022.100917_bb0175","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.ymthe.2020.03.018","article-title":"A highly efficacious PS gene editing system corrects metabolic and neurological complications of mucopolysaccharidosis type I","volume":"28","author":"Ou","year":"2020","journal-title":"Mol. Ther."},{"year":"1988","series-title":"Homo sapiens hemoglobin subunit alpha 1 (HBA1), mRNA [Internet]","key":"10.1016\/j.ymgmr.2022.100917_bb0180"},{"year":"1988","series-title":"Homo sapiens hemoglobin subunit alpha 2 (HBA2), mRNA [Internet]","key":"10.1016\/j.ymgmr.2022.100917_bb0185"},{"year":"1988","series-title":"Mus musculus hemoglobin alpha, adult chain 1 (Hba-a1), mRNA [Internet]","key":"10.1016\/j.ymgmr.2022.100917_bb0190"},{"key":"10.1016\/j.ymgmr.2022.100917_bb0195","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0022-2836(05)80360-2","article-title":"Basic local alignment search tool","volume":"215","author":"Altschul","year":"1990","journal-title":"J. Mol. Biol."},{"author":"Codon Optimization Tool","key":"10.1016\/j.ymgmr.2022.100917_bb0200"},{"key":"10.1016\/j.ymgmr.2022.100917_bb0205","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1073\/pnas.252784899","article-title":"Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB","volume":"100","author":"Ohmi","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.ymgmr.2022.100917_bb0210","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ymgme.2009.08.002","article-title":"Characterization of an MPS I-H knock-in mouse that carries a nonsense mutation analogous to the human IDUA-W402X mutation","volume":"99","author":"Wang","year":"2010","journal-title":"Mol. Genet. Metab."},{"issue":"6","key":"10.1016\/j.ymgmr.2022.100917_bb0215","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.brainresbull.2007.07.018","article-title":"Characterization of an immunodeficient mouse model of mucopolysaccharidosis type I suitable for preclinical testing of human stem cell and gene therapy","volume":"74","author":"Garcia-Rivera","year":"2007","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ymgmr.2022.100917_bb0220","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S1096-7192(03)00116-1","article-title":"Treatment of the mouse model of mucopolysaccharidosis I with retrovirally transduced bone marrow","volume":"79","author":"Zheng","year":"2003","journal-title":"Mol. Genet. Metab."},{"author":"The Institutional Animal Care and Use Committee","key":"10.1016\/j.ymgmr.2022.100917_bb0225"},{"key":"10.1016\/j.ymgmr.2022.100917_bb0230","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1073\/pnas.1222742110","article-title":"Engineering a lysosomal enzyme with a derivative of receptor-binding domain of apoE enables delivery across the blood-brain barrier","volume":"110","author":"Wang","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgmr.2022.100917_bb0235","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/mt.2008.119","article-title":"Targeting of the CNS in MPS-IH using a nonviral transferrin-alpha-L-iduronidase fusion gene product","volume":"16","author":"Osborn","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgmr.2022.100917_bb0240","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ymgme.2013.11.009","article-title":"Standardization of \u03b1-L-iduronidase enzyme assay with Michaelis\u2013Menten kinetics","volume":"111","author":"Ou","year":"2014","journal-title":"Mol. Genet. Metab."},{"year":"2021","series-title":"Catalog number abx253700","author":"C. Human Alpha-L-iduronidase (IDUA) ELISA Kit","key":"10.1016\/j.ymgmr.2022.100917_bb0245"},{"author":"UniProtKB - P35475 (IDUA_HUMAN)","key":"10.1016\/j.ymgmr.2022.100917_bb0250"},{"key":"10.1016\/j.ymgmr.2022.100917_bb0255","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/BF01062139","article-title":"Testing for the equality of area under the curves when using destructive measurement techniques","volume":"16","author":"Bailer","year":"1988","journal-title":"J. Pharmacokinet. Biopharm."},{"key":"10.1016\/j.ymgmr.2022.100917_bb0260","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/10543409808835241","article-title":"An extension of Satterthwaite\u2019s approximation applied to pharmacokinetics","volume":"8","author":"Nedelman","year":"1998","journal-title":"J. Biopharm. Stat."},{"key":"10.1016\/j.ymgmr.2022.100917_bb0265","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1081\/BIP-100104199","article-title":"Comments on Nedelman and Jia\u2019s extension of Satterthwaite\u2019s approximation applied to pharmacokinetics","volume":"11","author":"Holder","year":"2001","journal-title":"J. Biopharm. Stat."},{"key":"10.1016\/j.ymgmr.2022.100917_bb0270","doi-asserted-by":"crossref","first-page":"8547","DOI":"10.1074\/jbc.M212030200","article-title":"Novel natural peptide substrates for endopeptidase 24.15, neurolysin, and angiotensin-converting enzyme","author":"Rioli","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgmr.2022.100917_bb0275","doi-asserted-by":"crossref","first-page":"36944","DOI":"10.1074\/jbc.M112.382481","article-title":"Identification and quantification of a new family of peptide endocannabinoids (Pepcans) showing negative allosteric modulation at CB1 receptors","volume":"287","author":"Bauer","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgmr.2022.100917_bb0280","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1046\/j.1471-4159.1999.0730493.x","article-title":"Internalization and recycling of the CB1 cannabinoid receptor","volume":"73","author":"Hsieh","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymgmr.2022.100917_bb0285","first-page":"3020","article-title":"Novel endogenous peptide agonists of cannabinoid receptors","volume":"23","author":"Gomes","year":"2009","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.ymgmr.2022.100917_bb0290","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.pharep.2017.05.015","article-title":"Anorexigenic effects induced by RVD-hemopressin(\u03b1) administration","volume":"69","author":"Ferrante","year":"2017","journal-title":"Pharmacol. Rep.: PR"},{"key":"10.1016\/j.ymgmr.2022.100917_bb0295","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.nlm.2016.07.030","article-title":"Effects of the cannabinoid 1 receptor peptide ligands hemopressin, (m)RVD-hemopressin(\u03b1) and (m)VD-hemopressin(\u03b1) on memory in novel object and object location recognition tasks in normal young and A\u03b21\u201342-treated mice","volume":"134","author":"Zhang","year":"2016","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.ymgmr.2022.100917_bb0300","doi-asserted-by":"crossref","first-page":"20588","DOI":"10.1073\/pnas.0706980105","article-title":"Hemopressin is an inverse agonist of CB1 cannabinoid receptors","volume":"104","author":"Heimann","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"year":"1988","series-title":"alpha-L-iduronidase isoform a precursor [Homo sapiens] [Internet]","key":"10.1016\/j.ymgmr.2022.100917_bb0305"},{"key":"10.1016\/j.ymgmr.2022.100917_bb0310","doi-asserted-by":"crossref","first-page":"D1","DOI":"10.1093\/nar\/gkaa1100","article-title":"UniProt: the universal protein knowledgebase in 2021","volume":"49","author":"The UniProt Consortium","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymgmr.2022.100917_bb0315","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.addr.2012.09.039","article-title":"Fusion protein linkers: property, design and functionality","volume":"65","author":"Chen","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ymgmr.2022.100917_bb0320","doi-asserted-by":"crossref","DOI":"10.3390\/genes9030136","article-title":"Translational advances of Hydrofection by hydrodynamic injection","volume":"9","author":"Sendra","year":"2018","journal-title":"Genes"},{"key":"10.1016\/j.ymgmr.2022.100917_bb0325","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1038\/sj.mt.6300314","article-title":"Hydrodynamic gene delivery: its principles and applications","volume":"15","author":"Suda","year":"2007","journal-title":"Mol. Ther."},{"author":"ORFfinder [Internet]","key":"10.1016\/j.ymgmr.2022.100917_bb0330"},{"author":"SnapGene\u00ae software","key":"10.1016\/j.ymgmr.2022.100917_bb0335"},{"year":"2015","series-title":"Considerations for the Design of Early-Phase Clinical Trials of Cellular and Gene Therapy Products","key":"10.1016\/j.ymgmr.2022.100917_bb0340"},{"key":"10.1016\/j.ymgmr.2022.100917_bb0345","doi-asserted-by":"crossref","first-page":"8375","DOI":"10.1073\/pnas.0803715105","article-title":"Infused Fc-tagged \u03b2-glucuronidase crosses the placenta and produces clearance of storage in utero in mucopolysaccharidosis VII mice","volume":"105","author":"Grubb","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgmr.2022.100917_bb0350","unstructured":"MOTIF Search. Kyoto University Bioinformatics Center. Accessed Oct 17 2021. https:\/\/www.genome.jp\/tools\/motif\/."},{"key":"10.1016\/j.ymgmr.2022.100917_bb0355","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/nar\/30.1.276","article-title":"The Pfam protein families database","volume":"30","author":"Bateman","year":"2002","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymgmr.2022.100917_bb0360","doi-asserted-by":"crossref","first-page":"D265","DOI":"10.1093\/nar\/gkz991","article-title":"CDD\/SPARCLE: the conserved domain database in 2020","volume":"48","author":"Lu","year":"2020","journal-title":"Nucleic Acids Res."},{"author":"PROSITE","key":"10.1016\/j.ymgmr.2022.100917_bb0365"},{"key":"10.1016\/j.ymgmr.2022.100917_bb0370","first-page":"605","article-title":"Sorting of lysosomal proteins. Biochimica et Biophysica Acta (BBA) - molecular","volume":"1793","author":"Braulke","year":"2009","journal-title":"Cell Res."},{"key":"10.1016\/j.ymgmr.2022.100917_bb0375","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3390\/ijms18010047","article-title":"Subcellular trafficking of mammalian lysosomal proteins: an extended view","volume":"18","author":"Staudt","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymgmr.2022.100917_bb0380","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/0022-2836(90)90085-Z","article-title":"An investigation of oligopeptides linking domains in protein tertiary structures and possible candidates for general gene fusion","volume":"211","author":"Argos","year":"1990","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ymgmr.2022.100917_bb0385","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1073\/pnas.0712147105","article-title":"Chemically modified beta-glucuronidase crosses blood-brain barrier and clears neuronal storage in murine mucopolysaccharidosis VII","volume":"105","author":"Grubb","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgmr.2022.100917_bb0390","doi-asserted-by":"crossref","first-page":"15172","DOI":"10.1073\/pnas.0607053103","article-title":"Enzyme therapy in mannose receptor-null mucopolysaccharidosis VII mice defines roles for the mannose 6-phosphate and mannose receptors","volume":"103","author":"Sly","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgmr.2022.100917_bb0395","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.addr.2021.01.017","article-title":"Current progress and limitations of AAV mediated delivery of protein therapeutic genes and the importance of developing quantitative pharmacokinetic\/pharmacodynamic (PK\/PD) models","volume":"170","author":"Chowdhury","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ymgmr.2022.100917_bb0400","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078161","article-title":"Quantitative analysis of \u03b1-L-iduronidase expression in immunocompetent mice treated with the sleeping beauty transposon system","volume":"8","author":"Aronovich","year":"2013","journal-title":"PLoS One"}],"container-title":["Molecular Genetics and Metabolism Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426922000775?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426922000775?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:53:25Z","timestamp":1762001605000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214426922000775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":80,"alternative-id":["S2214426922000775"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgmr.2022.100917","relation":{},"ISSN":["2214-4269"],"issn-type":[{"type":"print","value":"2214-4269"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of a novel fusion Iduronidase with improved activity in the cardiovascular system","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgmr.2022.100917","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100917"}}